BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 15052177)

  • 1. [Medical termination of pregnancy at 9-14 weeks gestation. Prospective study of 105 cases in Saint-Laurent-du-Maroni (French Guyana)].
    Largeaud M; El Guindi W; Perotti F; Montoya Y; Carles G; Seve B
    J Gynecol Obstet Biol Reprod (Paris); 2004 Apr; 33(2):119-24. PubMed ID: 15052177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
    Ashok PW; Flett GM; Templeton A
    Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
    Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
    Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and safety of mifepristone combined with misoprostol for termination of pregnancy between 8 and 16 weeks of gestation].
    Qian J; Jing X; Wu S; Zheng S; Li Y; Ren M; Di W; Shen H; Dong B; Chang Q; Shi H; Yao C; Song W; Huang Z
    Zhonghua Fu Chan Ke Za Zhi; 2015 Jul; 50(7):505-9. PubMed ID: 26311640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study on the use of sublingual misoprostol with mifepristone in termination of first trimester pregnancy up to 9 weeks gestation.
    Tang OS; Xu J; Cheng L; Lee SW; Ho PC
    Hum Reprod; 2002 Jul; 17(7):1738-40. PubMed ID: 12093832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent use of mifepristone and misoprostol for early medical abortion.
    Li YT; Chen FM; Chen TH; Li SC; Chen ML; Kuo TC
    Taiwan J Obstet Gynecol; 2006 Dec; 45(4):325-8. PubMed ID: 17175491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous use of mifepristone and misoprostol for early pregnancy termination.
    Li YT; Hsieh JC; Hou GQ; Chen TH; Chu YC; Lin TC; Kuan LC; Lin M; Tang HH; Kuo TC
    Taiwan J Obstet Gynecol; 2011 Mar; 50(1):11-4. PubMed ID: 21482367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    Hum Reprod; 2005 Aug; 20(8):2348-54. PubMed ID: 15878927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of mifepristone and sublingual misoprostol for early medical abortion.
    Lin M; Li YT; Chen FM; Wu SF; Tsai CW; Chen TH; Kuo TC
    Taiwan J Obstet Gynecol; 2006 Dec; 45(4):321-4. PubMed ID: 17175490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion.
    Schaff EA; Fielding SL; Westhoff C
    Contraception; 2001 Aug; 64(2):81-5. PubMed ID: 11704083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation.
    Tang OS; Chan CC; Ng EH; Lee SW; Ho PC
    Hum Reprod; 2003 Nov; 18(11):2315-8. PubMed ID: 14585880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of a hospital outpatient day procedure for medication abortion at 13-18 weeks gestation: Findings from Nepal
    Blum J; Karki C; Tamang A; Shochet T; Shrestha A; Tuladhar H; Karki A; Sharma J; Abbas DF; Dragoman M; Winikoff B
    Contraception; 2019 Dec; 100(6):451-456. PubMed ID: 31491379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous administration of mifepristone and misoprostol for early termination of pregnancy: a randomized controlled trial.
    Goel A; Mittal S; Taneja BK; Singal N; Attri S
    Arch Gynecol Obstet; 2011 Jun; 283(6):1409-13. PubMed ID: 21431329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First trimester abortion with mifepristone and vaginal misoprostol.
    Knudsen UB
    Contraception; 2001 May; 63(5):247-50. PubMed ID: 11448463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mifepristone followed by misoprostol or oxytocin for second-trimester abortion: a randomized controlled trial.
    Elami-Suzin M; Freeman MD; Porat N; Rojansky N; Laufer N; Ben-Meir A
    Obstet Gynecol; 2013 Oct; 122(4):815-820. PubMed ID: 24084539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Practical guidance for termination of pregnancy at 8 to 16 weeks gestation with mifepristone and misoprostol].
    Chinese Society of Family Planning, Chinese Medical Association
    Zhonghua Fu Chan Ke Za Zhi; 2015 May; 50(5):321-2. PubMed ID: 26311448
    [No Abstract]   [Full Text] [Related]  

  • 19. Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial.
    von Hertzen H; Huong NT; Piaggio G; Bayalag M; Cabezas E; Fang AH; Gemzell-Danielsson K; Hinh ND; Mittal S; Ng EH; Chaturachinda K; Pinter B; Puscasiu L; Savardekar L; Shenoy S; Khomassuridge A; Tuyet HT; Velasco A; Peregoudov A;
    BJOG; 2010 Sep; 117(10):1186-96. PubMed ID: 20560941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
    Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.